Morocco’s HIV Testing Shortages Reveal Deep-Seated Procurement Failures

An alarming paradox persists in Morocco’s public health system: while rapid HIV test kits sit unused in storage, doctors send patients home without screening due to chronic shortages. This discrepancy isn’t merely a logistical oversight—it exposes a fundamental flaw in the country’s public procurement system, where national preference laws remain unenforced despite clear legal mandates.

Legal Loopholes Undermine Local Production

The Moroccan Public Procurement Law (Decree n° 2.22.431) explicitly prohibits exclusionary bidding practices, requiring technical specifications to be performance-based rather than brand-specific. Yet, according to Abdelhay Rhorba, a public law expert at Hassan II University of Casablanca, many tender documents still favor foreign manufacturers through overly restrictive criteria.

«When tender conditions are crafted to exclude domestic producers—even unintentionally—it violates the principle of fair competition and may constitute an abuse of power», Rhorba explains. Moroccan administrative courts scrutinize such cases using a simple test: whether the specifications unjustly shut out local competitors.

Legal recourse exists—challenging bids via the National Public Procurement Commission or filing administrative lawsuits within 60 days—but the process demands resources few possess when battling entrenched bureaucracy.

Technical Specifications Favor Imports Over Local Innovation

Field reports reveal that technical specifications documents (CPS)—which define procurement requirements—often reflect outdated foreign products rather than adapting to Morocco’s growing manufacturing capabilities. A local medical device manufacturer, speaking anonymously, described a «Kafkaesque» system where his company supplies African markets but holds less than 2% of Morocco’s public procurement share in its sector.

«Tender documents rarely prioritize Moroccan-made alternatives, even when equivalent or superior products exist», the manufacturer noted. Attempts to flag biased specifications to procurement authorities typically meet with silence or inaction.

Government Policies Send Mixed Signals

The contradiction extends beyond healthcare. While the Ministry of Finance has raised tariffs on imported medical devices to boost local production, the Ministry of Health continues purchasing costly foreign alternatives despite competitive domestic options.

When questioned, the Directorate of Drug and Health Product Procurement defended its practices, stating that tenders are «open to all operators meeting the criteria, with priority given to Moroccan-based entities». However, the ministry clarified that this preference applies to company registration—not manufacturing origin. Essentially, foreign-owned distributors operating in Morocco receive the same treatment as local producers.

HIV Test Shortages: A Case Study in Systemic Failure

The HIV test crisis epitomizes these flaws. Some public health facilities faced stockouts lasting over a year, yet local manufacturers with approved, ready-to-ship kits were overlooked. The Ministry of Health attributed delays to «international supply chain disruptions» and «procurement procedural timelines», while simultaneously denying any use of emergency sole-source contracts—a claim disputed by sector insiders.

Under Decree n° 2.22.431, sole-source contracts are permitted only under strict conditions: unforeseeable urgency, technical exclusivity, or failed tenders. «Without documented proof of these criteria, such contracts are illegal», Rhorba emphasized.

Sovereign Health Ambitions Collide With Reality

Jaafar Heikel, a prominent infectious disease specialist, underscored the stakes: «Rapid tests aren’t just about diagnosis—they enable outreach to populations that avoid traditional clinics. NGOs like OPALS and ALCS rely on these tools to test marginalized groups».

Local production could cut costs and enhance supply chain resilience, Heikel added. «When the state validates Moroccan-made tests, it strengthens both financial sustainability and public health autonomy».

2030 Targets in Jeopardy Without Reform

Morocco has pledged to meet the UNAIDS 95-95-95 targets by 2030—ensuring 95% of people with HIV know their status, receive treatment, and achieve viral suppression. These goals hinge on widespread, accessible testing. Yet, without reliable supply chains and fair procurement, progress stalls.

«Every stockout means missed diagnoses—and missed opportunities to end the epidemic», a local manufacturer warned. The Ministry of Health insists it remains «fully committed to uninterrupted testing services», but sector observers demand tangible changes in tender specifications and enforcement.

As frustration grows, questions arise: Are some procurement officials shielding foreign suppliers or their own interests? The risk is clear—if innovators see their compliant products systematically rejected, investment in Morocco’s health sector will dwindle. The result? Continued dependence on imports for goods the country can produce itself.